| | | | | |
PRLD Prelude Therapeutics Incorporated | €4.8999 | +6.11 % | €349.11M | €445.98K | |
| €18.8356 | +1.17 % | €348.98M | €90.85K | |
ALTI AlTi Global, Inc. Class A Common Stock | €3.5909 | +1.65 % | €348.93M | €96.80K | |
HELP Cybin Inc. Common Stock | €9.7216 | +11.00 % | €348.69M | €1.96M | |
STRO Sutro Biopharma, Inc. | €17.6490 | -18.80 % | €347.35M | €494.80K | |
NPAC New Providence Acquisition Corp. III Class A Ordinary Shares | €9.0567 | +0.09 % | €347.22M | €22.87K | |
CCAP Crescent Capital BDC, Inc. Common stock | €9.6956 | -2.36 % | €347.00M | €131.44K | |
SWMR Swarmer, Inc Common Stock | €34.4075 | +0.43 % | €346.95M | €132.92K | |
| €5.9380 | -0.71 % | €346.55M | €213.77K | |
LSAK Lesaka Technologies, Inc. Common Stock | €4.1317 | -1.45 % | €346.29M | €29.52K | |
CCIX Churchill Capital Corp IX Ordinary Shares | €9.4438 | +0.00 % | €346.23M | €68.98K | |
BTQ BTQ Technologies Corp. Common Stock | €3.7715 | -1.92 % | €345.89M | €994.12K | |
FNLC First Bancorp, Inc. (ME) | €30.7784 | +0.11 % | €345.68M | €9.79K | |
SDHY PGIM Short Duration High Yield Opportunities Fund | €14.1441 | -0.28 % | €345.22M | €21.37K | |
LRMR Larimar Therapeutics, Inc. Common Stock | €3.7645 | +0.63 % | €344.90M | €478.90K | |
